MSRPS
RETA

Maryland State Retirement & Pension System’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Maryland State Retirement & Pension System’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,032
Closed -$203K – 1002
2021
Q1 		$203K Buy
+2,032
New +$237K 0.01% 962

Other funds holding RETA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Maryland State Retirement & Pension System's RETA Position: Q2 2021 in Review

Maryland State Retirement & Pension System sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q2 2021, closing a stake of 2,032 shares — an estimated $203K sold.

Maryland State Retirement & Pension System first reported a position in RETA in Q1 2021 and held it in 1 quarter. The position peaked at $203K in Q1 2021. 194 funds tracked by Wall St. Rank hold RETA as of Q2 2021.

  • Maryland State Retirement & Pension System reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • Maryland State Retirement & Pension System sold 2,032 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q2 2021, an estimated $203K.
  • Maryland State Retirement & Pension System first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2021 and held it in 1 quarter.
  • Maryland State Retirement & Pension System's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $203K in Q1 2021.
  • 194 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q2 2021.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2021, filed 13 Jul 2021.